{
    "startDate": "2019-01-01",
    "endDate": "2019-12-31",
    "year": "2019",
    "quarter": "FY",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 2913700000.0
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 1562200000.0
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1880500000.0
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DueFromUnconsolidatedJointBusiness",
                "unit": "usd",
                "value": 590200000.0
            },
            {
                "label": "Components of inventories",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 804200000.0
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 631000000.0
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 8381799999.999999
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesNoncurrent",
                "unit": "usd",
                "value": 1408100000.0
            },
            {
                "label": "Total property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3247300000.0
            },
            {
                "label": "Operating lease assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 427000000.0
            },
            {
                "label": "Intangible assets",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3527400000.0
            },
            {
                "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5757800000.0
            },
            {
                "label": "Deferred tax asset",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 3232100000.0
            },
            {
                "label": "Prepaid research and development",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1252800000.0
            },
            {
                "label": "Assets:",
                "concept": "Assets",
                "unit": "usd",
                "value": 27234300000.0
            },
            {
                "label": "Current portion of notes payable",
                "concept": "DebtCurrent",
                "unit": "usd",
                "value": 1495800000.0
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 71400000.0
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 530799999.99999994
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 2765800000.0
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 4863800000.0
            },
            {
                "label": "Total debt maturities",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 4459000000.0
            },
            {
                "label": "Deferred tax liability",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 2810800000.0
            },
            {
                "label": "Operating lease liability, noncurrent",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 412700000.0
            },
            {
                "label": "Other Liabilities, Noncurrent",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1348900000.0
            },
            {
                "label": "Liabilities:",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 13895200000.0
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000.0
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax Beginning Balance",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -135200000.0
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 16455400000.000002
            },
            {
                "label": "Repurchase of common stock, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000.0
            },
            {
                "label": "Beginning Balance",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 13343200000.0
            },
            {
                "label": "Beginning Balance",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -4099999.9999999995
            },
            {
                "label": "Beginning Balance",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 13339100000.0
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 27234300000.0
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 5888500000.0
            },
            {
                "label": "Depreciation, amortization and impairments",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 680600000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 182300000.0
            },
            {
                "label": "Deferred",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 67099999.99999999
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 63700000.0
            },
            {
                "label": "Income (Loss) from Individually Significant Component Disposed of or Held-for-sale, Excluding Discontinued Operations, Attributable to Parent, before Income Tax",
                "concept": "IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsAttributableToParentBeforeIncomeTax",
                "unit": "usd",
                "value": -55300000.0
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -69200000.0
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -68800000.0
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": 63300000.0
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 19200000.0
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 240200000.0
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 16100000.000000002
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": -43300000.0
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 7078600000.0
            },
            {
                "label": "Proceeds from maturities and sales",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 6007000000.0
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecurities",
                "unit": "usd",
                "value": 5252600000.0
            },
            {
                "label": "Contingent consideration related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": 300000000.0
            },
            {
                "label": "Payments to Acquire Businesses, Net of Cash Acquired",
                "concept": "PaymentsToAcquireBusinessesNetOfCashAcquired",
                "unit": "usd",
                "value": 744400000.0
            },
            {
                "label": "Proceeds from Sale of Property, Plant, and Equipment",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 923700000.0
            },
            {
                "label": "Payments to Acquire in Process Research and Development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 514500000.0
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 155000000.0
            },
            {
                "label": "Payments to Acquire Other Investments",
                "concept": "PaymentsToAcquireOtherInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Payments to increase investment in Samsung Bioepis",
                "concept": "PaymentsToAcquireEquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Sale of Ionis common stock",
                "concept": "ProceedsFromSaleOfAvailableForSaleSecuritiesEquity",
                "unit": "usd",
                "value": 479300000.0
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": -27000000.0
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 470500000.0
            },
            {
                "label": "Payments for repurchase of common stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 5868300000.0
            },
            {
                "label": "Payment to Neurimmune",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": -4300000.0
            },
            {
                "label": "Repayments of borrowings",
                "concept": "RepaymentsOfDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash contribution to Bioverativ, Inc.",
                "concept": "PaymentsOfCapitalDistribution",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Contingent consideration payments",
                "concept": "PaymentsToAcquireProductiveAssets",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 3600000.0
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -5860400000.0
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
                "unit": "usd",
                "value": 1688700000.0
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 400000.0
            }
        ],
        "ic": [
            {
                "label": "Net income attributable to Biogen Idec Inc",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 5888500000.0
            },
            {
                "label": "Unrealized gains (losses) recognized during the period, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 11800000.0
            },
            {
                "label": "Less: reclassification adjustment for (gains) losses included in net income, net of tax",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
                "unit": "usd",
                "value": 3600000.0
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": 8199999.999999999
            },
            {
                "label": "Unrealized gains (losses) recognized during the period, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 88100000.0
            },
            {
                "label": "Less: reclassification adjustment for (gains) losses included in net income, net of tax",
                "concept": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
                "unit": "usd",
                "value": 115000000.0
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax",
                "unit": "usd",
                "value": -26900000.0
            },
            {
                "label": "Gains (Losses) on net investment hedge recognized during period",
                "concept": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
                "unit": "usd",
                "value": 28600000.0
            },
            {
                "label": "Less: Reclassification of net investment hedge forward points amortization",
                "concept": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsAfterTax",
                "unit": "usd",
                "value": 7000000.0
            },
            {
                "label": "Gains (losses) on net investment hedges",
                "concept": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax",
                "unit": "usd",
                "value": 21600000.0
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": 1500000.0
            },
            {
                "label": "Currency translation adjustment",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": 103800000.0
            },
            {
                "label": "Other comprehensive income (loss), net of tax",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 105200000.0
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 5993700000.0
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -400000.0
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 5993300000.0
            },
            {
                "label": "Revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 14377900000.0
            },
            {
                "label": "Cost of sales, excluding amortization and impairment of acquired intangible assets",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1955400000.0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 2280600000.0
            },
            {
                "label": "Selling, General and Administrative Expenses",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 2374700000.0
            },
            {
                "label": "Amortization and impairment of acquired intangible assets",
                "concept": "biib:AmortizationandImpairmentofAcquiredIntangibleAssets",
                "unit": "usd",
                "value": 489900000.0
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:CollaborationProfitSharing",
                "unit": "usd",
                "value": 241600000.0
            },
            {
                "label": "Loss on divestiture of Hiller\u00f8d, Denmark manufacturing operations",
                "concept": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown",
                "unit": "usd",
                "value": 55300000.0
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "(Gain) loss on fair value remeasurement of contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 63700000.0
            },
            {
                "label": "Restructuring Charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 1500000.0
            },
            {
                "label": "Cost and expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 7335300000.0
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 7042600000.0
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 83300000.0
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 7125900000.0
            },
            {
                "label": "Income tax expense",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 1158000000.0
            },
            {
                "label": "Equity in loss of investee, net of tax",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -79400000.0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 5888500000.0
            },
            {
                "label": "Net income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 31.47
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 31.42
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 187100000.0
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 187400000.0
            }
        ]
    }
}